Protagenic Therapeutics (STU:MBP) Shares Buyback Ratio % : -2.63 (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Protagenic Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Protagenic Therapeutics's current shares buyback ratio was -2.63%.

Protagenic Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Protagenic Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protagenic Therapeutics Shares Buyback Ratio % Chart

Protagenic Therapeutics Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.97

-66.11

-0.44

-2.63

Protagenic Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-0.22	-	-2.41	-

Protagenic Therapeutics Shares Buyback Ratio % Calculation

Protagenic Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(4.32132	-	4.43513)	/	4.32132
	=	-2.63%

Protagenic Therapeutics's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(4.43513	-	4.43513)	/	4.43513
	=	0.00%

Protagenic Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Protagenic Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Protagenic Therapeutics (STU:MBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protagenic Therapeutics Inc (STU:MBP) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

PTIX:USA

Address

149 Fifth Avenue, Suite 500, New York, NY, USA, 10010

Website

https://www.protagenic.com

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Protagenic Therapeutics (STU:MBP) Headlines

No Headlines